Abbott Laboratories (ABT) Cash & Equivalents Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.32% |
| Dec 31, 2025 | 4.50% |
| Sep 30, 2025 | 10.89% |
| Jun 30, 2025 | 7.85% |
| Mar 31, 2025 | 14.10% |
| Dec 31, 2024 | 14.56% |
| Sep 30, 2024 | 13.06% |
| Jun 30, 2024 | 17.37% |
| Mar 31, 2024 | 15.77% |
| Dec 31, 2023 | 6.71% |
| Sep 30, 2023 | -1.86% |
| Jun 30, 2023 | 20.65% |
| Mar 31, 2023 | 18.89% |
| Dec 31, 2022 | -1.19% |
| Sep 30, 2022 | -2.72% |
| Jun 30, 2022 | -1.57% |
| Mar 31, 2022 | -2.49% |
| Dec 31, 2021 | -14.72% |
| Sep 30, 2021 | 30.06% |
| Jun 30, 2021 | 27.42% |
| Mar 31, 2021 | 19.29% |
| Dec 31, 2020 | 6.46% |
| Sep 30, 2020 | 7.42% |
| Jun 30, 2020 | 3.31% |
| Mar 31, 2020 | 0.92% |
| Dec 31, 2019 | -1.02% |
| Sep 30, 2019 | 2.52% |
| Jun 30, 2019 | -2.55% |
| Mar 31, 2019 | 7.97% |
| Dec 31, 2018 | 7.47% |
| Sep 30, 2018 | 20.65% |
| Jun 30, 2018 | -11.27% |
| Mar 31, 2018 | -2.48% |
| Dec 31, 2017 | -0.58% |
| Sep 30, 2017 | 6.61% |
| Jun 30, 2017 | 6.53% |
| Mar 31, 2017 | 14.91% |
| Dec 31, 2016 | 26.10% |
| Sep 30, 2016 | -13.12% |
| Jun 30, 2016 | -8.76% |
| Mar 31, 2016 | 4.00% |
| Dec 31, 2015 | 6.51% |
| Sep 30, 2015 | -3.88% |
| Jun 30, 2015 | -1.30% |
| Mar 31, 2015 | 11.52% |
| Dec 31, 2014 | -14.34% |
| Sep 30, 2014 | -5.82% |
| Jun 30, 2014 | -3.22% |